About organogenesis holdings inc - ORGO
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
ORGO At a Glance
Organogenesis Holdings, Inc.
85 Dan Road
Canton, Massachusetts 02021
| Phone | 1-781-575-0775 | Revenue | 564.17M | |
| Industry | Medical Specialties | Net Income | 37.03M | |
| Sector | Health Technology | 2025 Sales Growth | 17.037% | |
| Fiscal Year-end | 12 / 2026 | Employees | 854 | |
| View SEC Filings |
ORGO Valuation
| P/E Current | 15.029 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 33.702 |
| Price to Sales Ratio | 1.196 |
| Price to Book Ratio | 2.191 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 9.557 |
| Enterprise Value to Sales | 1.411 |
| Total Debt to Enterprise Value | 0.103 |
ORGO Efficiency
| Revenue/Employee | 660,619.438 |
| Income Per Employee | 43,362.998 |
| Receivables Turnover | 2.594 |
| Total Asset Turnover | 1.029 |
ORGO Liquidity
| Current Ratio | 3.617 |
| Quick Ratio | 3.321 |
| Cash Ratio | 0.942 |
ORGO Profitability
| Gross Margin | 70.849 |
| Operating Margin | 9.994 |
| Pretax Margin | 8.326 |
| Net Margin | 6.564 |
| Return on Assets | 6.754 |
| Return on Equity | 9.041 |
| Return on Total Capital | 7.176 |
| Return on Invested Capital | 8.077 |
ORGO Capital Structure
| Total Debt to Total Equity | 18.929 |
| Total Debt to Total Capital | 15.916 |
| Total Debt to Total Assets | 13.719 |
| Long-Term Debt to Equity | 21.156 |
| Long-Term Debt to Total Capital | 12.304 |